M&A Deal Summary

Bio-Techne Acquires CyVek

On November 4, 2014, Bio-Techne acquired life science company CyVek for 60M USD

Acquisition Highlights
  • This is Bio-Techne’s 2nd transaction in the Life Science sector.
  • This is Bio-Techne’s 7th largest (disclosed) transaction.
  • This is Bio-Techne’s 4th transaction in the United States.
  • This is Bio-Techne’s 1st transaction in Connecticut.

M&A Deal Summary
Date 2014-11-04
Target CyVek
Sector Life Science
Buyer(s) Bio-Techne
Deal Type Add-on Acquisition
Deal Value 60M USD

Target

CyVek

Wallingford, Connecticut, United States
CyVek, Inc., is a biotech company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for testing biomarkers and performing multi-analyte immunoassays.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bio-Techne

Minneapolis, Minnesota, United States
Category Company
Founded 1976
Sector Life Science
Employees3,200
Revenue 1.1B USD (2023)
DESCRIPTION
Bio-Techne's corporate headquarters in Minneapolis, Minnesota.
Bio-Techne's corporate headquarters in Minneapolis, Minnesota.

Bio-Techne is a life sciences company that provides bioactive tools and resources for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. Bio-Techne was founded in 1976 and is based in Minneapolis, Minnesota.

DEAL STATS #
Overall 4 of 18
Sector (Life Science) 2 of 11
Type (Add-on Acquisition) 4 of 17
State (Connecticut) 1 of 1
Country (United States) 4 of 15
Year (2014) 3 of 3
Size (of disclosed) 7 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-08-01 ProteinSimple

Santa Clara, California, United States

ProteinSimple develops instrumentation systems, software and assay products that drive discoveries in fields ranging from fundamental protein research to biomarker discovery and personalized medicine.

Buy $300M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-06-05 Cliniqa

San Marcos, California, United States

Cliniqa Corp. is a developer, manufacturer and distributer of control solutions that verify the proper operation of in vitro diagnostic (IVD) devices, with a primary focus on blood chemistry.

Buy -
Mergr

Product

Company

Legal